AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Visirimir M 1000mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Uniza Healthcare LLP

Salt Composition

Metformin (1000mg) + Vildagliptin (50mg)

Overview Visirimir M 1000mg/50mg Tablet

Combiflex DM 1000mg/50mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like kidney impairment and vision loss, potentially lowering the risk of cardiovascular events such as heart attack or stroke. Combiflex DM 1000mg/50mg tablets may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy necessitates adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, blood glucose readings, and concurrent medications. Ingesting the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar control is crucial for preventing future complications. Continued commitment to the prescribed diet and exercise regimen is essential. Lifestyle choices significantly influence diabetes management. Commonly reported side effects include diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, especially when co-administered with insulin or sulfonylureas; patients should be educated on its recognition and management. This medication is not universally suitable. Prior to commencing treatment, individuals with pre-existing kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption should consult their physician. Pregnant or lactating women should seek medical advice. Potential drug interactions necessitate comprehensive disclosure of all medications to the prescribing physician to ensure patient safety. Alcohol intake should be minimized due to its potential to lower blood glucose levels. Kidney function and blood glucose will be monitored by your doctor before and throughout the treatment period.

Uses of Visirimir M 1000mg/50mg Tablet

Managing Type 2 Diabetes

Major Benefits of Visirimir M 1000mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Visirimir M 1000mg/50mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Visirimir M 1000mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Visirimir M 1000mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the Visirimir M 1000mg/50mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Visirimir M 1000mg/50mg Tablet works:

Each Visirimir M tablet (1000mg/50mg) contains a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Visirimir M 1000mg/50mg Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Visirimir M 1000mg/50mg Tablet during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Visirimir M 1000mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Visirimir M 1000mg/50mg tablets cautiously. Dosage modifications for Visirimir M 1000mg/50mg tablets may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should not take Visirimir M 1000mg/50mg tablets; use is potentially hazardous. Seek medical advice.

What if you forget to take Visirimir M 1000mg/50mg Tablet :

Should you forget a Visirimir M 1000mg/50mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Visirimir M 1000mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Visirimir M 1000mg/50mg Tablet

Visirimir M 1000mg/50mg tablets rarely cause hypoglycemia by themselves. However, low blood sugar can occur if insufficient calories are consumed while using this medication. Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advised.
Nausea and vomiting are possible side effects of Visirimir M 1000mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take additional medication without your doctor's approval.
Visimir M 1000mg/50mg Tablets are contraindicated in patients allergic to any component. This medication should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Visirimir M 1000mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Visirimir M 1000mg/50mg Tablets can, rarely, cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This risk is higher in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms appear, discontinue use and seek immediate medical attention.
Prolonged use of Visirimir M 1000mg/50mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological issues.
Visirimir M 1000mg/50mg Tablet is safe when used as directed by your doctor. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia, especially with insulin or sulfonylurea) may occur. Report any persistent issues to your physician.
Visirimir M 1000mg/50mg T...
56
MRP 65
13% off